<b>Conclusion:</b> <sup>68</sup>Ga-PSMA-11 PET/CT is a robust and independent prognostic marker in patients with unfavorable intermediate- or high-risk PCa and may help tailor treatments and improve outcomes. Here, FOLH1 is linked to posterior cortical atrophy.